...
首页> 外文期刊>Journal of experimental & clinical cancer research : >Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC)
【24h】

Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC)

机译:圆形RNA循环CPA4 / Let-7 miRNA / PD-L1轴调节非小细胞肺癌(NSCLC)中的细胞生长,茎,耐药性和免疫逃避

获取原文
           

摘要

Non-small cell lung cancer (NSCLC) cells derived intracellular and extracellular programmed cell death ligand 1 (PD-L1) promoted cancer progression and drug resistance, and facilitated tumor immune evasion. However, the detailed molecular mechanisms are still largely unknown. In the present study, we aimed to explore the role of circular RNA circ-CPA4/let-7 miRNA/PD-L1 axis in the regulation of NSCLC progression, drug resistance and tumor immune microenvironment. Real-Time qPCR and Western Blot analysis were conducted to examine gene expressions at transcriptional and translated levels, respectively. The regulatory mechanisms of circ-CPA4, let-7 miRNA and PD-L1 were validated by dual-luciferase reporter gene system and RNA pull-down assay. Cell growth and apoptosis were determined by CCK-8 assay, colony formation assay and Annexin V-FITC/PI double staining assay. Cell mobility was evaluated by transwell assay. Circ-CPA4 and PD-L1 were high-expressed, while let-7 miRNA was low-expressed in NSCLC cells and cancer tissues compared to the human bronchial epithelial (HBE) cells and their paired clinical normal adjacent tissues, respectively. Besides, knock-down of circ-CPA4 inhibited cell growth, mobility and epithelial-mesenchymal transition (EMT), and promoted cell death in NSCLC cells by downregulating PD-L1 through serving as a RNA sponge for let-7 miRNA. In addition, the NSCLC cells derived PD-L1-containing exosomes promoted cell stemness and increased resistance of NSCLC cells to cisplatin. Notably, by co-culturing the NSCLC cells with CD8 T cells isolated from human peripheral blood mononuclear cells (hPBMCs) in a transwell co-culturing system, we found that NSCLC cells inactivated CD8 T cells in a secreted PD-L1-dependent manner. Further results suggested that circ-CPA4 also positively regulated exosomal PD-L1, and the NSCLC cells with circ-CPA4 ablation re-activated CD8 T cells in the co-culturing system. Taken together, circ-CPA4 regulated cell growth, mobility, stemness and drug resistance in NSCLC cells and inactivated CD8 T cells in the tumor immune microenvironment through let-7 miRNA/PD-L1 axis.
机译:衍生细胞内和细胞外细胞死亡配体1(PD-L1)的非小细胞肺癌(NSCLC)细胞促进癌症进展和耐药性,促进肿瘤免疫逃逸。然而,详细的分子机制仍然很大程度上是未知的。在本研究中,我们旨在探讨圆形RNA循环CPA4 / Let-7 miRNA / PD-L1轴在NSCLC进展,耐药性和肿瘤免疫微环境的调节中的作用。进行实时QPCR和Western印迹分析,以分别检查转录和翻译水平的基因表达。通过双荧光素酶报告基因系统和RNA下拉测定验证了循环CPA4,Let-7 miRNA和PD-L1的调节机制。通过CCK-8测定,菌落形成测定和膜蛋白V-FITC / PI双染色测定法测定细胞生长和细胞凋亡。通过Transwell测定评估细胞迁移率。循环CPA4和PD-L1高表达,而与人支气管上皮(HBE)细胞及其成对的临床正常相邻的组织相比,Let-7 miRNA低于NSCLC细胞和癌组织。此外,通过将Pd-L1作为RNA海绵用于Let-7 miRNA,通过用作Let-7 miRNA的RNA海绵,循环循环抑制细胞生长,迁移率和上皮 - 间充质转换(EMT),并促进了NSCLC细胞中的细胞死亡。此外,NSCLC细胞衍生的含PD-L1的外索体促进细胞茎,并且NSCLC细胞对顺铂的增加。值得注意的是,通过将NSCLC细胞与来自副培养系统中的人外周血单核细胞(HPBMC)分离的CD8 T细胞共同培养,我们发现NSCLC细胞以分泌的PD-L1依赖性方式灭活CD8 T细胞。进一步的结果表明,循环CPA4也具有阳性辐射的外泌体PD-L1和NSCLC细胞,其中具有循环CPA4消融在共培养系统中的CD8 T细胞。在一起,CIRC-CPA4在NSCLC细胞中的迁移率,茎和耐药性,通过Let-7 miRNA / Pd-L1轴线在肿瘤免疫微环境中灭活CD8 T细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号